Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

29

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

29 results for “Neuromuscular fatigue”

Learn how ShareScore rates datasets ↗
zenodo48/100

Dataset Effect of hypnotic suggestion on knee extensor neuromuscular properties in resting and fatigued states

<p>The .xlsx file contains individual data from all figures / tables of the associated manuscript and each .csv file contains information from one figure / table.</p> <p>&nbsp;</p> <p><strong>Dataset Fig 2</strong></p> <p>Table 1. Maximal voluntary contraction force (Newton) from the knee extensor muscles measured before (pre) and after (post) control / hypnosis suggestion</p> <p>Table 2. Maximal voluntary activation level (%) from the knee extensor muscles measured before (pre) and after (post) control / hypnosis suggestion</p> <p>Table 3. Peak doublet force (Newton) evoked from 100 Hz paired stimuli at the knee extensor level measured before (pre) and after (post) control / hypnosis suggestion</p> <p>&nbsp;</p> <p><strong>Dataset Fig 4</strong></p> <p>Table 1. Time to task failure (s) of a submaximal isometric contraction performed at 20% maximal voluntary contraction force with the knee extensors for the control session and the hypnosis session</p> <p>&nbsp;</p> <p><strong>Dataset Fig 5</strong></p> <p>Table 1. Maximal voluntary contraction force (Newton) from the knee extensor muscles measured before (pre exercise) and after (post exercise) exercise during the control session and the hypnosis session</p> <p>Table 2. Maximal voluntary activation level (%) from the knee extensor muscles measured before (pre exercise) and after (post exercise) exercise during the control session and the hypnosis session</p> <p>Table 3. Peak doublet force (Newton) evoked from 100 Hz paired stimuli at the knee extensor level measured before (pre exercise) and after (post exercise) exercise during the control session and the hypnosis session</p> <p>&nbsp;</p> <p><strong>Dataset Fig 6</strong></p> <p>Table 1. Electromyographic activity (in %, expressed as root mean square values normalized to maximal electromyographic activity measured during the maximal voluntary contraction performed before exercise) of the vastus lateralis muscle measured during the sustained isometric contraction at every 25% of time to task failure for the control session and the hypnosis session</p> <p>Table 2. Electromyographic activity (in %, expressed as root mean square values normalized to maximal electromyographic activity measured during the maximal voluntary contraction performed before exercise) of the vastus medialis muscle measured during the sustained isometric contraction at every 25% of time to task failure for the control session and the hypnosis session</p> <p>Table 3. Electromyographic activity (in %, expressed as root mean square values normalized to maximal electromyographic activity measured during the maximal voluntary contraction performed before exercise) of the rectus femoris muscle measured during the sustained isometric contraction at every 25% of time to task failure for the control session and the hypnosis session</p> <p>&nbsp;</p> <p><strong>Dataset Fig 7</strong></p> <p>Table 1. Motor evoked potential peak to peak amplitude from the vastus lateralis muscle measured during the sustained isometric contraction at every 50% of time to task failure for the control session and the hypnosis session. Values are expressed in %, i.e. expressed as a ratio between the motor evoked potential peak-to-peak amplitude expressed in mV (Table 2) and the peak-to-peak M-wave amplitude expressed in mV (Table 3).</p> <p>Table 4. Motor evoked potential peak to peak amplitude from the vastus medialis muscle measured during the sustained isometric contraction at every 50% of time to task failure for the control session and the hypnosis session. Values are expressed in %, i.e. expressed as a ratio between the motor evoked potential peak-to-peak amplitude expressed in mV (Table 5) and the peak-to-peak M-wave amplitude expressed in mV (Table 6).</p> <p>Table 7. Motor evoked potential peak to peak amplitude from the rectus femoris muscle measured during the sustained isometric contraction at every 50% of time to task failure for the control session and the hypnosis session. Values are expressed in %, i.e. expressed as a ratio between the motor evoked potential peak-to-peak amplitude expressed in mV (Table 8) and the peak-to-peak M-wave amplitude expressed in mV (Table 9).</p> <p>Table 10. Short intracortical inhibition peak to peak amplitude from the vastus lateralis muscle measured during the sustained isometric contraction at every 50% of time to task failure for the control session and the hypnosis session. Values are expressed in %, i.e. expressed as a ratio between the short intracortical inhibition peak-to-peak amplitude expressed in mV (Table 11) and the motor evoked potential peak-to-peak amplitude expressed in mV (Table 12).</p> <p>Table 13. Short intracortical inhibition peak to peak amplitude from the vastus medialis muscle measured during the sustained isometric contraction at every 50% of time to task failure for the control session and the hypnosis session. Values are expressed in %, i.e. expressed as a ratio between the short intracortical inhibition peak-to-peak amplitude expressed in mV (Table 14) and the motor evoked potential peak-to-peak amplitude expressed in mV (Table 15).</p> <p>Table 16. Short intracortical inhibition peak to peak amplitude from the rectus femoris muscle measured during the sustained isometric contraction at every 50% of time to task failure for the control session and the hypnosis session. Values are expressed in %, i.e. expressed as a ratio between the short intracortical inhibition peak-to-peak amplitude expressed in mV (Table 17) and the motor evoked potential peak-to-peak amplitude expressed in mV (Table 18).</p> <p><br> <strong>Dataset Fig 8</strong></p> <p>Table 1. Rate of perceived exertion (6-20 Borg scale) measured during the sustained isometric contraction at every 25% of time to task failure for the control session and the hypnosis session</p> <p>&nbsp;</p> <p><strong>Dataset Table 1</strong></p> <p>Table 1. Motor evoked potential peak to peak amplitude from the vastus lateralis muscle measured before (pre) and after (post) control / hypnosis suggestion. Values are expressed in %, i.e. expressed as a ratio between the motor evoked potential peak-to-peak amplitude expressed in mV (Table 2) and the peak-to-peak M-wave amplitude expressed in mV (Table 3).</p> <p>Table 4. Motor evoked potential peak to peak amplitude from the vastus medialis muscle measured before (pre) and after (post) control / hypnosis suggestion. Values are expressed in %, i.e. expressed as a ratio between the motor evoked potential peak-to-peak amplitude expressed in mV (Table 5) and the peak-to-peak M-wave amplitude expressed in mV (Table 6).</p> <p>Table 7. Motor evoked potential peak to peak amplitude from the rectus femoris muscle measured before (pre) and after (post) control / hypnosis suggestion. Values are expressed in %, i.e. expressed as a ratio between the motor evoked potential peak-to-peak amplitude expressed in mV (Table 8) and the peak-to-peak M-wave amplitude expressed in mV (Table 9).</p> <p>Table 10. Short intracortical inhibition peak to peak amplitude from the vastus lateralis muscle measured before (pre) and after (post) control / hypnosis suggestion. Values are expressed in %, i.e. expressed as a ratio between the short intracortical inhibition peak-to-peak amplitude expressed in mV (Table 11) and the motor evoked potential peak-to-peak amplitude expressed in mV (Table 12).</p> <p>Table 13. Short intracortical inhibition peak to peak amplitude from the vastus medialis muscle measured before (pre) and after (post) control / hypnosis suggestion. Values are expressed in %, i.e. expressed as a ratio between the short intracortical inhibition peak-to-peak amplitude expressed in mV (Table 14) and the motor evoked potential peak-to-peak amplitude expressed in mV (Table 15).</p> <p>Table 16. Short intracortical inhibition peak to peak amplitude from the rectus femoris muscle measured before (pre) and after (post) control / hypnosis suggestion. Values are expressed in %, i.e. expressed as a ratio between the short intracortical inhibition peak-to-peak amplitude expressed in mV (Table 17) and the motor evoked potential peak-to-peak amplitude expressed in mV (Table 18).</p> <p>&nbsp;</p> <p><strong>Dataset table 2</strong></p> <p>Table 1. M-wave peak to peak amplitude (mV) from the vastus lateralis muscle measured before (pre) and after (post) control / hypnosis suggestion</p> <p>Table 2. M-wave peak to peak amplitude (mV) from the vastus medialis muscle measured before (pre) and after (post) control / hypnosis suggestion</p> <p>Table 3. M-wave peak to peak amplitude (mV) from the rectus femoris muscle measured before (pre) and after (post) control / hypnosis suggestion</p>

opencc-by-4.0Apr 2018View details →
zenodo40/100

Individualized mental fatigue does not impact neuromuscular function and exercise performance

<p>Previous work has shown that mental fatigue may have negative consequences on cognitive or physical performance, although recent reports question this previous empirical evidence. Here, we investigate the critical role of inter-individual differences in susceptibility to develop mental fatigue by measuring neurophysiological and physical responses to an individualized mental fatigue task. We expected mental load to alter both subjective, i.e., increased subjective perception of fatigue, and objective markers of fatigue, i.e., impaired knee extensor neuromuscular function, impaired corticospinal excitability and reduced cerebral oxygenation. Even though all participants performed a similar mental effort, their performance in a subsequent exercise did not differ. Furthermore, even if there was an elevated subjective feeling of mental fatigue, none of the neurophysiological parameters were affected. The study provides new insights into an issue that has grown in popularity in recent years without questioning individual differences and which has taken for granted the detrimental effect of acute mental fatigue on performance.</p>

opencc-by-4.0Jan 2023View details →
ClinicalTrials.gov32/100

Effects of Neuromuscular Electrical Stimulation Parameters on Torque, Fatigue, and Oxygen Extraction

ClinicalTrials.gov study NCT05061056. IPD Sharing: NO. Countries: 1. Publications: 10.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Effect of Prolonged Military Exercises With High Load Carriage, on Neuromuscular Fatigue and Physiological/Biomechanical Responses

ClinicalTrials.gov study NCT01127191. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Effects of Mode of Contraction on Neuromuscular Fatigue

ClinicalTrials.gov study NCT04516538. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Perturbation Based Neuromuscular Training Effects on Peroneal Strength, Fatigue and Functional Performance Parameters

ClinicalTrials.gov study NCT05594628. IPD Sharing: NO. Countries: 1. Publications: 8.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Characterization of Neuromuscular Function and Fatigue After Breast Cancer Treated With Adjuvant Chemotherapy (PROTECT-04)

ClinicalTrials.gov study NCT04639609. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Neuromuscular Fatigue During Exercise in COPD-HF Overlap

ClinicalTrials.gov study NCT05235685. IPD Sharing: YES. Countries: 1. Publications: 7.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Neuromuscular Fatigue and Exercise Capacity in Patients With Type 2 Diabetes Mellitus and HFpEF

ClinicalTrials.gov study NCT06057623. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Neuromuscular Fatigue in Chronic Obstructive Pulonary Disease

ClinicalTrials.gov study NCT04028973. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Description of Physical Activity Effect on Neuromuscular Fatigue of Older People

ClinicalTrials.gov study NCT05413590. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Recovery of Performance, Muscle Damage and Neuromuscular Fatigue Following Muscle Power Training

ClinicalTrials.gov study NCT03936595. IPD Sharing: Not stated. Countries: 1. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Physiopathology of Neuromuscular Function Related to Fatigue in Chronic Renal Disease

ClinicalTrials.gov study NCT04330807. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Neuromuscular and Cognitive Fatigue During a 24 Hour Treadmill Running Exercise

ClinicalTrials.gov study NCT00428779. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Effect of Femoral Quadriceps Muscle Length on Fatigue Induced by Neuromuscular Electrical Stimulation

ClinicalTrials.gov study NCT05905406. IPD Sharing: NO. Countries: 0. Publications: 10.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Neuromuscular Fatigue Aetiology Comparison Between Prepubertal Boys and Adults

ClinicalTrials.gov study NCT03049241. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Effects of Running Shoe Sole Hardness on Vibration and Neuromuscular Fatigue During a Half-marathon Run on a Treadmill

ClinicalTrials.gov study NCT06110637. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Effects of Ankle Evertor Fatigue on Force Sense and Neuromuscular Activation in Subjects With Chronic Ankle Instability

ClinicalTrials.gov study NCT07252219. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov24/100

Effect of Neuromuscular Electrical Stimulation of Lower Limbs on Improving Exercise Self-Efficacy, Dyspnea During Activity and Fatigue in Patients With Chronic Obstructive Pulmonary Disease

ClinicalTrials.gov study NCT06851195. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Stimulation Sites and Fatigue Induced by Neuromuscular Electrical Stimulation in Healthy Individuals

ClinicalTrials.gov study NCT05605210. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record